Gunnar Casserstedt
Chairman at KD Incentive AB
Profile
Gunnar Casserstedt is currently the Chairman at KD Incentive AB.
Previously, he was the Deputy Chief Executive Officer & Executive VP at Karolinska Development AB, Chairman at KCIF Fund Management AB, Director at Neurotherapeutics AB and Modus Therapeutics Holding AB, and Chief Financial Officer at Sopherion Therapeutics LLC.
He also served as the Chief Financial Officer at Karolinska Development AB (Private Equity) from 2006 to 2012 and as the Vice President-Finance, Research & Development at Pharmacia, Inc.
Gunnar Casserstedt active positions
| Companies | Position | Start |
|---|---|---|
| KD Incentive AB | Chairman | - |
Former positions of Gunnar Casserstedt
| Companies | Position | End |
|---|---|---|
Neurotherapeutics AB
 Neurotherapeutics AB Miscellaneous Commercial ServicesCommercial Services Neurotherapeutics AB researches and develops pharmaceutical products. It identifies and delivers stem cell-based therapies for Parkinson's disease. The company was founded in 2003 by Ernest Arenas and is headquartered in Stockholm, Sweden. | Director/Board Member | 2012-01-18 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Director of Finance/CFO | 2011-12-31 |
| MODUS THERAPEUTICS HOLDING AB | Director/Board Member | - |
| KCIF Fund Management AB | Chairman | - |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| MODUS THERAPEUTICS HOLDING AB | Health Technology |
| Private companies | 6 |
|---|---|
Sopherion Therapeutics LLC
Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Finance |
| Pharmacia, Inc. | |
Neurotherapeutics AB
Neurotherapeutics AB Miscellaneous Commercial ServicesCommercial Services Neurotherapeutics AB researches and develops pharmaceutical products. It identifies and delivers stem cell-based therapies for Parkinson's disease. The company was founded in 2003 by Ernest Arenas and is headquartered in Stockholm, Sweden. | Commercial Services |
| KCIF Fund Management AB | |
| KD Incentive AB |
- Stock Market
- Insiders
- Gunnar Casserstedt
